Skip to content

Psychedelic-assisted therapy: all studies

Page 284 of 294: studies 2,831 to 2,840 of 2,936, newest first. Back to the psychedelic-assisted therapy overview

Research

Empathetic Reform and the Psychedelic Aesthetic: Women’s Accounts of LSD Therapy

Configurations December 1, 2014 Lana Cook 6 citations

Both written under pseudonym, Constance Newland’s My Self and I (1962) and Jane Dunlap’s Exploring Inner Space (1961) are firsthand accounts of psychedelic drug use taken in therapeutic research settings that demonstrate how women’s access to discursive legitimacy was negotiated in mid-twentieth-century life-writing. Newland and Dunlap use realism to connect readers to their psychedelic...

Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles.

Therapeutic Advances in Psychopharmacology August 1, 2014 David Baumeister, Georgina Barnes, Giovanni Giaroli et al.

Hallucinogens have been part of spiritual practice for millennia, but controversy surrounding their mind-manifesting effects led to their proscription by the mid-20th century, largely without evidence of harm or toxicity and despite nascent data suggesting therapeutic utility in treating depressive illnesses. This review explores their pharmacodynamic actions and the current limited data on...

3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress Disorder.

Annals of Pharmacotherapy July 2014 C Michael White

Review the current literature assessing the role of 3,4-methylenedioxymethamphetamine (MDMA) on posttraumatic stress disorder (PTSD). OVID MEDLINE search (1960-February 2014) using the terms MDMA, 3,4-methylenedioxymethamphetamine, Molly, and Ecstasy crossed with posttraumatic stress disorder with backwards citation tracking using references from procured articles. English language studies...

Regarding the Transpersonal Nature of Ketamine Therapy: An Approach to the Work

International Journal of Transpersonal Studies July 1, 2014 Jeffrey Becker 8 citations

Recent evidence has shown that ketamine treatment can facilitate psychological insight and symptom resolution in various psychiatric disorders.To aid this process, psychotherapeutic support should be considered a fundamental aspect of treatment.The psychedelic experience produced by ketamine can be a deeply meaningful source of enduring change and personal growth.The author has repeatedly...

Psychedelic Experiential Pharmacology: Pioneering Clinical Explorations with Salvador Roquet (How I Came to All of This: Ketamine, Admixtures and Adjuvants, Don Juan and Carlos Castaneda Too): An Interview with Richard Yensen

International Journal of Transpersonal Studies July 1, 2014 Philip E. Wolfson 20 citations

Richard Yensen was a research fellow at the Maryland Psychiatric Research Center from 1972 to 1976. He studied psychedelic psychotherapy with Stanislav Grof, M.D. and other senior staff. During this time he treated patients with substance abuse disorders, cancer, neurosis, and other health professionals seeking a training experience. Dr. Yensen did his Ph.D. dissertation on the use of MDA in...

DOI: 10.24972/ijts.2014.33.2.160 (opens in new tab) Ketamine Experiential learning Psychoanalysis Psychotherapist

Neurociencias y aplicaciones psicoterapéuticas en el renacimiento de la investigación con psicodélicos

Revista chilena de neuro-psiquiatría June 1, 2014 S Christopher Timmermann 7 citations

El objetivo de esta revisión consiste en exponer los principales avances en la investigación reciente con sustancias psicodélicas en las neurociencias y sus aplicaciones psioterapéuticas. La acción de la psilocibina, un agonista del receptor 5-HT2A, ha sido asociada a una desactivación en la Default Mode Network (activada durante la introspección y pensamientos auto-referentes), un mayor acceso...

MDMA is certainly damaging after 25 years of empirical research: a reply and refutation of Doblin et al. (2014).

Human Psychopharmacology: Clinical and Experimental March 2014 Andrew C. Parrott

Human Psychopharmacology recently published my review into the increase in empirical knowledge about the human psychobiology of MDMA over the past 25 years (Parrott, 2013a). Deficits have been demonstrated in retrospective memory, prospective memory, higher cognition, complex visual processing, sleep architecture, sleep apnoea, pain, neurohormonal activity, and psychiatric status. Neuroimaging...

A reconsideration and response to Parrott AC (2013) "Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research".

Human Psychopharmacology: Clinical and Experimental March 1, 2014 Rick Doblin, George Greer, Julie Holland et al. 48 citations

Parrott recently published a review of literature on MDMA/ecstasy. This commentary is a response to the content and tenor of his review, which mischaracterizes the literature through misstatement and omission of contrary findings, and fails to address the central controversies in the literature. The review makes several erroneous statements concerning MDMA-assisted psychotherapy, such as...

DOI: 10.1002/hup.2389 (opens in new tab) MDMA Ecstasy Therapeutic potential Controlled therapeutic contexts +6

Results of a Transpersonal, Narrative, and Phenomenological Psychotherapy for Psychosis

CIIS Digital Commons 2014 Lewis Mehl‐Madrona, Erik Jul, Barbara Mainguy 6 citations

In our academically based, psychiatric outpatient practice, we have encountered those who wish to avoid medications for treatment for psychosis. This study is a qualitative/quantitative study in progress of a patient population diagnosed with psychosis and managed primarily without medication. We reflect upon the transpersonal foundations of an approach in which voices and visions are accepted...

Why Psychiatry Needs Psychedelics and Psychedelics Need Psychiatry

Journal of Psychoactive Drugs 2014 B. Sessa 26 citations

Without researching psychedelic drugs for medical therapy, psychiatry is turning its back on a group of compounds that could have great potential. Without the validation of the medical profession, the psychedelic drugs, and those who take them off-license, remain archaic sentiments of the past, with the users maligned as recreational drug abusers and subject to continued negative opinion. These...